SSI Strategy to acquires NDA Group partner to form global life sciences consultancy
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
The inspection was conducted from August 7 to August 11, 2023 and concluded without any observations.
Doxycycline Hyclate Delayed-Release Tablets USP (RLD Doryx ) had estimated annual sales of USD 9 million in the U.S. (IQVIA MAT June 2023).
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated